Thomas Jefferson University

Paolo Fortina

TitleVolunteer Faculty
InstitutionThomas Jefferson University
DepartmentPharmacology & Exp Therapeutic
Address1025 Walnut St.
Philadelphia PA 19107
Phone215-955-0683
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R21CA083220     (FORTINA, PAOLO M)Sep 26, 2000 - Apr 30, 2002
    NIH
    FOUR COLOR ARRAY BOUND SNP/MUTATION DETECTION IN CANCER
    Role: Principal Investigator
    R33CA083220     (FORTINA, PAOLO M)Sep 26, 2000 - Apr 30, 2006
    NIH
    FOUR COLOR ARRAY BOUND SNP/MUTATION DETECTION IN CANCER
    Role: Principal Investigator
    S10OD025128     (FORTINA, PAOLO M)Aug 27, 2020 - Aug 26, 2021
    NIH
    Ultrahigh Throughput Sequencing System
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Thangavel C, Boopathi E, Ciment S, Liu Y, O'Neill R, Sharma A, McMahon SB, Mellert H, Addya S, Ertel A, Birbe R, Fortina P, Dicker AP, Knudsen KE, Den RB. Correction: The Retinoblastoma Tumor Suppressor Modulates DNA Repair and Radioresponsiveness. Clin Cancer Res. 2024 Dec 16; 30(24):5695. PMID: 39676540.
      Citations:    
    2. Piera-Velazquez S, Fortina P, Jimenez SA. Comparison of serum exosome miRNA from patients with Raynaud's phenomenon with positive and negative serum antinuclear antibodies. Clin Exp Rheumatol. 2024 Aug; 42(8):1629-1634. PMID: 39152754.
      Citations:    
    3. Schepps S, Xu J, Yang H, Mandel J, Mehta J, Tolotta J, Baker N, Tekmen V, Nikbakht N, Fortina P, Fuentes I, LaFleur B, Cho RJ, South AP. Skin in the game: a review of single-cell and spatial transcriptomics in dermatological research. Clin Chem Lab Med. 2024 Sep 25; 62(10):1880-1891. PMID: 38656304.
      Citations:    
    4. Rajpar I, Kumar G, Fortina P, Tomlinson RE. Toll-like receptor 4 signaling in osteoblasts is required for load-induced bone formation in mice. iScience. 2023 Apr 21; 26(4):106304. PMID: 36950122.
      Citations:    
    5. Rasouli J, Casella G, Zhang W, Xiao D, Kumar G, Fortina P, Zhang GX, Ciric B, Rostami A. Transcription Factor RUNX3 Mediates Plasticity of ThGM Cells Toward Th1 Phenotype. Front Immunol. 2022; 13:912583. PMID: 35860266.
      Citations:    
    6. Saeidian AH, Youssefian L, Huang CY, Palizban F, Naji M, Saffarian Z, Mahmoudi H, Goodarzi A, Sotoudeh S, Vahidnezhad F, Amani M, Tavakoli N, Ajami A, Mozafarpoor S, Teimoorian M, Dorgaleleh S, Shokri S, Shenagari M, Abedi N, Zeinali S, Fortina P, B?ziat V, Jouanguy E, Casanova JL, Uitto J, Vahidnezhad H. Whole-transcriptome sequencing-based concomitant detection of viral and human genetic determinants of cutaneous lesions. JCI Insight. 2022 04 22; 7(8). PMID: 35316210.
      Citations:    
    7. Hope JL, Zhao M, Stairiker CJ, Kiernan CH, Carey AJ, Mueller YM, van Meurs M, Brouwers-Haspels I, Otero DC, Bae EA, Faso HA, Maas A, de Looper H, Fortina PM, Rigoutsos I, Bradley LM, Erkeland SJ, Katsikis PD. MicroRNA-139 Expression Is Dispensable for the Generation of Influenza-Specific CD8+ T Cell Responses. J Immunol. 2022 02 01; 208(3):603-617. PMID: 35022277.
      Citations:    
    8. Rappaport JA, Entezari AA, Caspi A, Caksa S, Jhaveri AV, Stanek TJ, Ertel A, Kupper J, Fortina PM, McMahon SB, Jaynes JB, Snook AE, Waldman SA. A ?-Catenin-TCF-Sensitive Locus Control Region Mediates GUCY2C Ligand Loss in Colorectal Cancer. Cell Mol Gastroenterol Hepatol. 2022; 13(4):1276-1296. PMID: 34954189.
      Citations:    
    9. Dasgeb B, Pajouhanfar S, Jazayeri A, Schoenberg E, Kumar G, Fortina P, Berger AC, Uitto J. Novel PTCH1 and concurrent TP53 mutations in four patients with numerous non-syndromic basal cell carcinomas: The paradigm of oncogenic synergy. Exp Dermatol. 2022 05; 31(5):736-742. PMID: 34862824.
      Citations:    
    10. Porazzi P, Petruk S, Pagliaroli L, De Dominici M, Deming D, Puccetti MV, Kushinsky S, Kumar G, Minieri V, Barbieri E, Deliard S, Grande A, Trizzino M, Gardini A, Canaani E, Palmisiano N, Porcu P, Ertel A, Fortina P, Eischen CM, Mazo A, Calabretta B. Targeting Chemotherapy to Decondensed H3K27me3-Marked Chromatin of AML Cells Enhances Leukemia Suppression. Cancer Res. 2022 02 01; 82(3):458-471. PMID: 34903608.
      Citations:    
    11. Saeidian AH, Youssefian L, Huang J, Touati A, Vahidnezhad H, Kowal L, Caffet M, Wurst T, Singh J, Snook AE, Ryu E, Fortina P, Terry SF, Schoenecker JG, Uitto J, Li Q. Genetic heterogeneity of heritable ectopic mineralization disorders in a large international cohort. Genet Med. 2022 01; 24(1):75-86. PMID: 34906475.
      Citations:    
    12. Dasgeb B, Leila Y, Saeidian AH, Kang J, Shi W, Shoenberg E, Ertel A, Fortina P, Vahidnezhad H, Uitto J. Genetic Predisposition to Numerous Large Ulcerating Basal Cell Carcinomas and Response to Immune Therapy. Int J Dermatol Venereol. 2021 Jun; 4(2):70-75. PMID: 34278326.
      Citations:    
    13. Rasouli J, Casella G, Ishikawa LLW, Thome R, Boehm A, Ertel A, Melo-Silva CR, Mari ER, Porazzi P, Zhang W, Xiao D, Sigal LJ, Fortina P, Zhang GX, Rostami A, Ciric B. IFN-? Acts on Monocytes to Ameliorate CNS Autoimmunity by Inhibiting Proinflammatory Cross-Talk Between Monocytes and Th Cells. Front Immunol. 2021; 12:679498. PMID: 34149716.
      Citations:    
    14. Youssefian L, Saeidian AH, Palizban F, Bagherieh A, Abdollahimajd F, Sotoudeh S, Mozafari N, Farahani RA, Mahmoudi H, Babashah S, Zabihi M, Zeinali S, Fortina P, Salas-Alanis JC, South AP, Vahidnezhad H, Uitto J. Whole-Transcriptome Analysis by RNA Sequencing for Genetic Diagnosis of Mendelian Skin Disorders in the Context of Consanguinity. Clin Chem. 2021 06 01; 67(6):876-888. PMID: 33969388.
      Citations:    
    15. Rasouli J, Casella G, Yoshimura S, Zhang W, Xiao D, Garifallou J, Gonzalez MV, Wiedeman A, Kus A, Mari ER, Fortina P, Hakonarson H, Long SA, Zhang GX, Ciric B, Rostami A. A distinct GM-CSF+ T helper cell subset requires T-bet to adopt a TH1 phenotype and promote neuroinflammation. Sci Immunol. 2020 Oct 23; 5(52). PMID: 33097590.
      Citations:    
    16. Kricka LJ, Polevikov S, Park JY, Fortina P, Bernardini S, Satchkov D, Kolesov V, Grishkov M. Artificial Intelligence-Powered Search Tools and Resources in the Fight Against COVID-19. EJIFCC. 2020 Jun; 31(2):106-116. PMID: 32549878.
      Citations:    
    17. Quaglia F, Krishn SR, Daaboul GG, Sarker S, Pippa R, Domingo-Domenech J, Kumar G, Fortina P, McCue P, Kelly WK, Beltran H, Liu Q, Languino LR. Small extracellular vesicles modulated by aV?3 integrin induce neuroendocrine differentiation in recipient cancer cells. J Extracell Vesicles. 2020 May 24; 9(1):1761072. PMID: 32922691.
      Citations:    
    18. De Dominici M, Porazzi P, Xiao Y, Chao A, Tang HY, Kumar G, Fortina P, Spinelli O, Rambaldi A, Peterson LF, Petruk S, Barletta C, Mazo A, Cingolani G, Salvino JM, Calabretta B. Selective inhibition of Ph-positive ALL cell growth through kinase-dependent and -independent effects by CDK6-specific PROTACs. Blood. 2020 04 30; 135(18):1560-1573. PMID: 32040545.
      Citations:    
    19. Upton K, Modi A, Patel K, Kendsersky NM, Conkrite KL, Sussman RT, Way GP, Adams RN, Sacks GI, Fortina P, Diskin SJ, Maris JM, Rokita JL. Epigenomic profiling of neuroblastoma cell lines. Sci Data. 2020 04 14; 7(1):116. PMID: 32286315.
      Citations:    
    20. Chen J, Martindale JL, Abdelmohsen K, Kumar G, Fortina PM, Gorospe M, Rostami A, Yu S. RNA-Binding Protein HuR Promotes Th17 Cell Differentiation and Can Be Targeted to Reduce Autoimmune Neuroinflammation. J Immunol. 2020 04 15; 204(8):2076-2087. PMID: 32169842.
      Citations:    
    21. Kumar G, Ertel A, Feldman G, Kupper J, Fortina P. iSeqQC: a tool for expression-based quality control in RNA sequencing. BMC Bioinformatics. 2020 Feb 13; 21(1):56. PMID: 32054449.
      Citations:    
    22. Meyer LK, Huang BJ, Delgado-Martin C, Roy RP, Hechmer A, Wandler AM, Vincent TL, Fortina P, Olshen AB, Wood BL, Horton TM, Shannon KM, Teachey DT, Hermiston ML. Glucocorticoids paradoxically facilitate steroid resistance in T cell acute lymphoblastic leukemias and thymocytes. J Clin Invest. 2020 02 03; 130(2):863-876. PMID: 31687977.
      Citations:    
    23. Gobbi G, Carubbi C, Tagliazucchi GM, Masselli E, Mirandola P, Pigazzani F, Crocamo A, Notarangelo MF, Suma S, Paraboschi E, Maglietta G, Nagalla S, Pozzi G, Galli D, Vaccarezza M, Fortina P, Addya S, Ertel A, Bray P, Duga S, Berzuini C, Vitale M, Ardissino D. Sighting acute myocardial infarction through platelet gene expression. Sci Rep. 2019 12 20; 9(1):19574. PMID: 31863085.
      Citations:    
    24. Simonneau C, Yang J, Kong X, Kilker R, Edelstein L, Fortina P, Londin E, Horowitz A. Validation of a Miniaturized Permeability Assay Compatible with CRISPR-Mediated Genome-Wide Screen. Sci Rep. 2019 Oct 02; 9(1):14238. PMID: 31578372.
      Citations:    
    25. Greaves RF, Bernardini S, Ferrari M, Fortina P, Gouget B, Gruson D, Lang T, Loh TP, Morris HA, Park JY, Roessler M, Yin P, Kricka LJ. Key questions about the future of laboratory medicine in the next decade of the 21st century: A report from the IFCC-Emerging Technologies Division. Clin Chim Acta. 2019 Aug; 495:570-589. PMID: 31145895.
      Citations:    
    26. Youssefian L, Vahidnezhad H, Yousefi M, Saeidian AH, Azizpour A, Touati A, Nikbakht N, Hesari KK, Adib-Sereshki MM, Zeinali S, Mansoori B, Jazayeri A, Karamzadeh R, Fortina P, Jouanguy E, Casanova JL, Uitto J. Inherited Interleukin 2-Inducible T-Cell (ITK) Kinase Deficiency in Siblings With Epidermodysplasia Verruciformis and Hodgkin Lymphoma. Clin Infect Dis. 2019 05 17; 68(11):1938-1941. PMID: 30778533.
      Citations:    
    27. Paolillo C, Londin E, Fortina P. Single-Cell Genomics. Clin Chem. 2019 08; 65(8):972-985. PMID: 30872376.
      Citations:    
    28. Youssefian L, Vahidnezhad H, Saeidian AH, Touati A, Sotoudeh S, Mahmoudi H, Mansouri P, Daneshpazhooh M, Aghazadeh N, Hesari KK, Basiri M, Londin E, Kumar G, Zeinali S, Fortina P, Uitto J. Autosomal recessive congenital ichthyosis: Genomic landscape and phenotypic spectrum in a cohort of 125 consanguineous families. Hum Mutat. 2019 03; 40(3):288-298. PMID: 30578701.
      Citations:    
    29. Youssefian L, Vahidnezhad H, Saeidian AH, Mahmoudi H, Karamzadeh R, Kariminejad A, Huang J, Li L, Jannace TF, Fortina P, Zeinali S, White TW, Uitto J. A novel autosomal recessive GJB2-associated disorder: Ichthyosis follicularis, bilateral severe sensorineural hearing loss, and punctate palmoplantar keratoderma. Hum Mutat. 2019 02; 40(2):217-229. PMID: 30431684.
      Citations:    
    30. Teh JLF, Cheng PF, Purwin TJ, Nikbakht N, Patel P, Chervoneva I, Ertel A, Fortina PM, Kleiber I, HooKim K, Davies MA, Kwong LN, Levesque MP, Dummer R, Aplin AE. Correction: In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms. Cancer Discov. 2018 Dec; 8(12):1654. PMID: 30510016.
      Citations:    
    31. Tricoci P, Neely M, Whitley MJ, Edelstein LC, Simon LM, Shaw C, Fortina P, Moliterno DJ, Armstrong PW, Aylward P, White H, Van de Werf F, Jennings LK, Wallentin L, Held C, Harrington RA, Mahaffey KW, Bray PF. Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial. Blood Cells Mol Dis. 2018 09; 72:37-43. PMID: 30055940.
      Citations:    
    32. Lu H, Bowler N, Harshyne LA, Craig Hooper D, Krishn SR, Kurtoglu S, Fedele C, Liu Q, Tang HY, Kossenkov AV, Kelly WK, Wang K, Kean RB, Weinreb PH, Yu L, Dutta A, Fortina P, Ertel A, Stanczak M, Forsberg F, Gabrilovich DI, Speicher DW, Altieri DC, Languino LR. Exosomal av?6 integrin is required for monocyte M2 polarization in prostate cancer. Matrix Biol. 2018 09; 70:20-35. PMID: 29530483.
      Citations:    
    33. Teh JLF, Cheng PF, Purwin TJ, Nikbakht N, Patel P, Chervoneva I, Ertel A, Fortina PM, Kleiber I, HooKim K, Davies MA, Kwong LN, Levesque MP, Dummer R, Aplin AE. In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms. Cancer Discov. 2018 05; 8(5):568-581. PMID: 29496664.
      Citations:    
    34. Sponziello M, Benvenuti S, Gentile A, Pecce V, Rosignolo F, Virz? AR, Milan M, Comoglio PM, Londin E, Fortina P, Barnabei A, Appetecchia M, Marandino F, Russo D, Filetti S, Durante C, Verrienti A. Whole exome sequencing identifies a germline MET mutation in two siblings with hereditary wild-type RET medullary thyroid cancer. Hum Mutat. 2018 03; 39(3):371-377. PMID: 29219214.
      Citations:    
    35. De Dominici M, Porazzi P, Soliera AR, Mariani SA, Addya S, Fortina P, Peterson LF, Spinelli O, Rambaldi A, Martinelli G, Ferrari A, Iacobucci I, Calabretta B. Targeting CDK6 and BCL2 Exploits the "MYB Addiction" of Ph+ Acute Lymphoblastic Leukemia. Cancer Res. 2018 02 15; 78(4):1097-1109. PMID: 29233926.
      Citations:    
    36. Harenza JL, Diamond MA, Adams RN, Song MM, Davidson HL, Hart LS, Dent MH, Fortina P, Reynolds CP, Maris JM. Corrigendum: Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines. Sci Data. 2017 12 05; 4:170183. PMID: 29206221.
      Citations:    
    37. Vahidnezhad H, Youssefian L, Saeidian AH, Mahmoudi H, Touati A, Abiri M, Kajbafzadeh AM, Aristodemou S, Liu L, McGrath JA, Ertel A, Londin E, Kariminejad A, Zeinali S, Fortina P, Uitto J. Recessive mutation in tetraspanin CD151 causes Kindler syndrome-like epidermolysis bullosa with multi-systemic manifestations including nephropathy. Matrix Biol. 2018 03; 66:22-33. PMID: 29138120.
      Citations:    
    38. Youssefian L, Vahidnezhad H, Saeidian AH, Sotoudeh S, Mahmoudi H, Daneshpazhooh M, Aghazadeh N, Adams R, Ghanadan A, Zeinali S, Fortina P, Uitto J. Autosomal recessive congenital ichthyosis: CERS3 mutations identified by a next generation sequencing panel targeting ichthyosis genes. Eur J Hum Genet. 2017 11; 25(11):1282-1285. PMID: 28875980.
      Citations:    
    39. Vahidnezhad H, Youssefian L, Saeidian AH, Touati A, Sotoudeh S, Abiri M, Barzegar M, Aghazadeh N, Mahmoudi H, Norouz-Zadeh S, Hamid M, Zahabiyon M, Bagherian H, Zeinali S, Fortina P, Uitto J. Multigene Next-Generation Sequencing Panel Identifies Pathogenic Variants in Patients with Unknown Subtype of Epidermolysis Bullosa: Subclassification with Prognostic Implications. J Invest Dermatol. 2017 12; 137(12):2649-2652. PMID: 28830826.
      Citations:    
    40. Paolillo C, Mu Z, Rossi G, Schiewer MJ, Nguyen T, Austin L, Capoluongo E, Knudsen K, Cristofanilli M, Fortina P. Detection of Activating Estrogen Receptor Gene (ESR1) Mutations in Single Circulating Tumor Cells. Clin Cancer Res. 2017 Oct 15; 23(20):6086-6093. PMID: 28679775.
      Citations:    
    41. Kageyama K, Ohara M, Saito K, Ozaki S, Terai M, Mastrangelo MJ, Fortina P, Aplin AE, Sato T. Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis. J Transl Med. 2017 06 23; 15(1):145. PMID: 28645290.
      Citations:    
    42. Harenza JL, Diamond MA, Adams RN, Song MM, Davidson HL, Hart LS, Dent MH, Fortina P, Reynolds CP, Maris JM. Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines. Sci Data. 2017 03 28; 4:170033. PMID: 28350380.
      Citations:    
    43. Vahidnezhad H, Youssefian L, Saeidian AH, Zeinali S, Mansouri P, Sotoudeh S, Barzegar M, Mohammadi-Asl J, Karamzadeh R, Abiri M, McCormick K, Fortina P, Uitto J. Gene-Targeted Next Generation Sequencing Identifies PNPLA1 Mutations in Patients with a Phenotypic Spectrum of Autosomal Recessive Congenital Ichthyosis: The Impact of Consanguinity. J Invest Dermatol. 2017 03; 137(3):678-685. PMID: 27884779.
      Citations:    
    44. Vahidnezhad H, Youssefian L, Zeinali S, Saeidian AH, Sotoudeh S, Mozafari N, Abiri M, Kajbafzadeh AM, Barzegar M, Ertel A, Fortina P, Uitto J. Dystrophic Epidermolysis Bullosa: COL7A1 Mutation Landscape in a Multi-Ethnic Cohort of 152 Extended Families with High Degree of Customary Consanguineous Marriages. J Invest Dermatol. 2017 03; 137(3):660-669. PMID: 27899325.
      Citations:    
    45. Mu Z, Benali-Furet N, Uzan G, Znaty A, Ye Z, Paolillo C, Wang C, Austin L, Rossi G, Fortina P, Yang H, Cristofanilli M. Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer. Int J Mol Sci. 2016 Sep 30; 17(10). PMID: 27706044.
      Citations:    
    46. Vozikis A, Cooper DN, Mitropoulou C, Kambouris ME, Brand A, Dolzan V, Fortina P, Innocenti F, Lee MT, Leyens L, Macek M, Al-Mulla F, Prainsack B, Squassina A, Taruscio D, van Schaik RH, Vayena E, Williams MS, Patrinos GP. Test Pricing and Reimbursement in Genomic Medicine: Towards a General Strategy. Public Health Genomics. 2016; 19(6):352-363. PMID: 27676083.
      Citations:    
    47. Paolillo C, Londin E, Fortina P. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine. Scand J Clin Lab Invest Suppl. 2016; 245:S84-91. PMID: 27542004.
      Citations:    
    48. Kricka LJ, Fortina P, Park JY. Nanostructured luminescently labeled nucleic acids. Luminescence. 2017 Mar; 32(2):132-141. PMID: 27417153.
      Citations:    
    49. Gogoi P, Sepehri S, Zhou Y, Gorin MA, Paolillo C, Capoluongo E, Gleason K, Payne A, Boniface B, Cristofanilli M, Morgan TM, Fortina P, Pienta KJ, Handique K, Wang Y. Development of an Automated and Sensitive Microfluidic Device for Capturing and Characterizing Circulating Tumor Cells (CTCs) from Clinical Blood Samples. PLoS One. 2016; 11(1):e0147400. PMID: 26808060.
      Citations:    
    50. Liao Z, Gu L, Vergalli J, Mariani SA, De Dominici M, Lokareddy RK, Dagvadorj A, Purushottamachar P, McCue PA, Trabulsi E, Lallas CD, Gupta S, Ellsworth E, Blackmon S, Ertel A, Fortina P, Leiby B, Xia G, Rui H, Hoang DT, Gomella LG, Cingolani G, Njar V, Pattabiraman N, Calabretta B, Nevalainen MT. Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia. Mol Cancer Ther. 2015 Aug; 14(8):1777-93. PMID: 26026053.
      Citations:    
    51. Casimiro MC, Di Sante G, Crosariol M, Loro E, Dampier W, Ertel A, Yu Z, Saria EA, Papanikolaou A, Li Z, Wang C, Addya S, Lisanti MP, Fortina P, Cardiff RD, Tozeren A, Knudsen ES, Arnold A, Pestell RG. Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis. Oncotarget. 2015 Apr 20; 6(11):8525-38. PMID: 25940700.
      Citations:    
    52. Londin E, Loher P, Telonis AG, Quann K, Clark P, Jing Y, Hatzimichael E, Kirino Y, Honda S, Lally M, Ramratnam B, Comstock CE, Knudsen KE, Gomella L, Spaeth GL, Hark L, Katz LJ, Witkiewicz A, Rostami A, Jimenez SA, Hollingsworth MA, Yeh JJ, Shaw CA, McKenzie SE, Bray P, Nelson PT, Zupo S, Van Roosbroeck K, Keating MJ, Calin GA, Yeo C, Jimbo M, Cozzitorto J, Brody JR, Delgrosso K, Mattick JS, Fortina P, Rigoutsos I. Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs. Proc Natl Acad Sci U S A. 2015 Mar 10; 112(10):E1106-15. PMID: 25713380.
      Citations:    
    53. Knudsen ES, McClendon AK, Franco J, Ertel A, Fortina P, Witkiewicz AK. RB loss contributes to aggressive tumor phenotypes in MYC-driven triple negative breast cancer. Cell Cycle. 2015; 14(1):109-22. PMID: 25602521.
      Citations:    
    54. Park JY, Clark P, Londin E, Sponziello M, Kricka LJ, Fortina P. Clinical exome performance for reporting secondary genetic findings. Clin Chem. 2015 Jan; 61(1):213-20. PMID: 25414276.
      Citations:    
    55. Kricka LJ, Polsky TG, Park JY, Fortina P. The future of laboratory medicine - a 2014 perspective. Clin Chim Acta. 2015 Jan 01; 438:284-303. PMID: 25219903.
      Citations:    
    56. Cooper DN, Brand A, Dolzan V, Fortina P, Innocenti F, Michael Lee MT, Macek M, Al-Mulla F, Prainsack B, Squassina A, Vayena E, Vozikis A, Williams MS, Patrinos GP. Bridging genomics research between developed and developing countries: the Genomic Medicine Alliance. Per Med. 2014 Sep; 11(7):615-623. PMID: 29764053.
      Citations:    
    57. Thangavel C, Boopathi E, Ciment S, Liu Y, O'Neill R, Sharma A, McMahon SB, Mellert H, Addya S, Ertel A, Birbe R, Fortina P, Dicker AP, Knudsen KE, Den RB. The retinoblastoma tumor suppressor modulates DNA repair and radioresponsiveness. Clin Cancer Res. 2014 Nov 01; 20(21):5468-5482. PMID: 25165096.
      Citations:    
    58. Park JY, Kricka LJ, Clark P, Londin E, Fortina P. Clinical genomics: when whole genome sequencing is like a whole-body CT scan. Clin Chem. 2014 Nov; 60(11):1390-2. PMID: 25114273.
      Citations:    
    59. Londin ER, Adijanto J, Philp N, Novelli A, Vitale E, Perria C, Serra G, Alesi V, Surrey S, Fortina P. Donor splice-site mutation in CUL4B is likely cause of X-linked intellectual disability. Am J Med Genet A. 2014 Sep; 164A(9):2294-9. PMID: 24898194.
      Citations:    
    60. McDonald MK, Tian Y, Qureshi RA, Gormley M, Ertel A, Gao R, Aradillas Lopez E, Alexander GM, Sacan A, Fortina P, Ajit SK. Functional significance of macrophage-derived exosomes in inflammation and pain. Pain. 2014 Aug; 155(8):1527-1539. PMID: 24792623.
      Citations:    
    61. Fortina P, Al Khaja N, Al Ali MT, Hamzeh AR, Nair P, Innocenti F, Patrinos GP, Kricka LJ. Genomics into Healthcare: the 5th Pan Arab Human Genetics Conference and 2013 Golden Helix Symposium. Hum Mutat. 2014 May; 35(5):637-40. PMID: 24526565.
      Citations:    
    62. Londin ER, Hatzimichael E, Loher P, Edelstein L, Shaw C, Delgrosso K, Fortina P, Bray PF, McKenzie SE, Rigoutsos I. The human platelet: strong transcriptome correlations among individuals associate weakly with the platelet proteome. Biol Direct. 2014 Feb 14; 9:3. PMID: 24524654.
      Citations:    
    63. Simon LM, Edelstein LC, Nagalla S, Woodley AB, Chen ES, Kong X, Ma L, Fortina P, Kunapuli S, Holinstat M, McKenzie SE, Dong JF, Shaw CA, Bray PF. Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics. Blood. 2014 Apr 17; 123(16):e37-45. PMID: 24523238.
      Citations:    
    64. Londin ER, Clark P, Sponziello M, Kricka LJ, Fortina P, Park JY. Performance of exome sequencing for pharmacogenomics. Per Med. 2014; 12(2):109-115. PMID: 26257813.
      Citations:    
    65. Feldman GJ, Parvizi J, Levenstien M, Scott K, Erickson JA, Fortina P, Devoto M, Peters CL. Developmental dysplasia of the hip: linkage mapping and whole exome sequencing identify a shared variant in CX3CR1 in all affected members of a large multigeneration family. J Bone Miner Res. 2013 Dec; 28(12):2540-9. PMID: 23716478.
      Citations:    
    66. Park JY, Kricka LJ, Fortina P. Next-generation sequencing in the clinic. Nat Biotechnol. 2013 Nov; 31(11):990-2. PMID: 24213773.
      Citations:    
    67. Witkiewicz AK, Cox DW, Rivadeneira D, Ertel AE, Fortina P, Schwartz GF, Knudsen ES. The retinoblastoma tumor suppressor pathway modulates the invasiveness of ErbB2-positive breast cancer. Oncogene. 2014 Jul 24; 33(30):3980-91. PMID: 24121271.
      Citations:    
    68. Basile KJ, Abel EV, Dadpey N, Hartsough EJ, Fortina P, Aplin AE. In vivo MAPK reporting reveals the heterogeneity in tumoral selection of resistance to RAF inhibitors. Cancer Res. 2013 Dec 01; 73(23):7101-10. PMID: 24121492.
      Citations:    
    69. Pandey AS, San Antonio JD, Addya S, Surrey S, Fortina P, Van Bockstaele EJ, Veznedaroglu E. Mechanisms of endothelial cell attachment, proliferation, and differentiation on 4 types of platinum-based endovascular coils. World Neurosurg. 2014 Nov; 82(5):684-95. PMID: 23994074.
      Citations:    
    70. Zaorsky NG, Sun Y, Wang Z, Palmer J, Fortina PM, Solomides C, Werner-Wasik M, Dicker AP, Axelrod R, Campling B, Evans N, Cowan S, Lu B. Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumab. Cancer Biol Ther. 2013 Oct 01; 14(10):883-7. PMID: 23917487.
      Citations:    
    71. Cristofanilli M, Fortina P. Circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med. 2013 07 04; 369(1):93. PMID: 23822789.
      Citations:    
    72. Park JY, Fortina P, Kricka LJ. Genomic test validation for incidental findings. Clin Chem. 2014 Feb; 60(2):292-3. PMID: 23818443.
      Citations:    
    73. Haddad BR, Gu L, Mirtti T, Dagvadorj A, Vogiatzi P, Hoang DT, Bajaj R, Leiby B, Ellsworth E, Blackmon S, Ruiz C, Curtis M, Fortina P, Ertel A, Liu C, Rui H, Visakorpi T, Bubendorf L, Lallas CD, Trabulsi EJ, McCue P, Gomella L, Nevalainen MT. STAT5A/B gene locus undergoes amplification during human prostate cancer progression. Am J Pathol. 2013 Jun; 182(6):2264-75. PMID: 23660011.
      Citations:    
    74. Abel EV, Basile KJ, Kugel CH, Witkiewicz AK, Le K, Amaravadi RK, Karakousis GC, Xu X, Xu W, Schuchter LM, Lee JB, Ertel A, Fortina P, Aplin AE. Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3. J Clin Invest. 2013 May; 123(5):2155-68. PMID: 23543055.
      Citations:    
    75. Bray PF, McKenzie SE, Edelstein LC, Nagalla S, Delgrosso K, Ertel A, Kupper J, Jing Y, Londin E, Loher P, Chen HW, Fortina P, Rigoutsos I. The complex transcriptional landscape of the anucleate human platelet. BMC Genomics. 2013 Jan 16; 14:1. PMID: 23323973.
      Citations:    
    76. Londin E, Yadav P, Surrey S, Kricka LJ, Fortina P. Use of linkage analysis, genome-wide association studies, and next-generation sequencing in the identification of disease-causing mutations. Methods Mol Biol. 2013; 1015:127-46. PMID: 23824853.
      Citations:    
    77. Yu Z, Wang L, Wang C, Ju X, Wang M, Chen K, Loro E, Li Z, Zhang Y, Wu K, Casimiro MC, Gormley M, Ertel A, Fortina P, Chen Y, Tozeren A, Liu Z, Pestell RG. Cyclin D1 induction of Dicer governs microRNA processing and expression in breast cancer. Nat Commun. 2013; 4:2812. PMID: 24287487.
      Citations:    
    78. Thangavel C, Boopathi E, Ertel A, Lim M, Addya S, Fortina P, Witkiewicz AK, Knudsen ES. Regulation of miR106b cluster through the RB pathway: mechanism and functional targets. Cell Cycle. 2013 Jan 01; 12(1):98-111. PMID: 23255112.
      Citations:    
    79. van der Harst P, Zhang W, Mateo Leach I, Rendon A, Verweij N, Sehmi J, Paul DS, Elling U, Allayee H, Li X, Radhakrishnan A, Tan ST, Voss K, Weichenberger CX, Albers CA, Al-Hussani A, Asselbergs FW, Ciullo M, Danjou F, Dina C, Esko T, Evans DM, Franke L, G?gele M, Hartiala J, Hersch M, Holm H, Hottenga JJ, Kanoni S, Kleber ME, Lagou V, Langenberg C, Lopez LM, Lyytik?inen LP, Melander O, Murgia F, Nolte IM, O'Reilly PF, Padmanabhan S, Parsa A, Pirastu N, Porcu E, Portas L, Prokopenko I, Ried JS, Shin SY, Tang CS, Teumer A, Traglia M, Ulivi S, Westra HJ, Yang J, Zhao JH, Anni F, Abdellaoui A, Attwood A, Balkau B, Bandinelli S, Bastardot F, Benyamin B, Boehm BO, Cookson WO, Das D, de Bakker PI, de Boer RA, de Geus EJ, de Moor MH, Dimitriou M, Domingues FS, D?ring A, Engstr?m G, Eyjolfsson GI, Ferrucci L, Fischer K, Galanello R, Garner SF, Genser B, Gibson QD, Girotto G, Gudbjartsson DF, Harris SE, Hartikainen AL, Hastie CE, Hedblad B, Illig T, Jolley J, K?h?nen M, Kema IP, Kemp JP, Liang L, Lloyd-Jones H, Loos RJ, Meacham S, Medland SE, Meisinger C, Memari Y, Mihailov E, Miller K, Moffatt MF, Nauck M, Novatchkova M, Nutile T, Olafsson I, Onundarson PT, Parracciani D, Penninx BW, Perseu L, Piga A, Pistis G, Pouta A, Puc U, Raitakari O, Ring SM, Robino A, Ruggiero D, Ruokonen A, Saint-Pierre A, Sala C, Salumets A, Sambrook J, Schepers H, Schmidt CO, Sillj? HH, Sladek R, Smit JH, Starr JM, Stephens J, Sulem P, Tanaka T, Thorsteinsdottir U, Tragante V, van Gilst WH, van Pelt LJ, van Veldhuisen DJ, V?lker U, Whitfield JB, Willemsen G, Winkelmann BR, Wirnsberger G, Algra A, Cucca F, d'Adamo AP, Danesh J, Deary IJ, Dominiczak AF, Elliott P, Fortina P, Froguel P, Gasparini P, Greinacher A, Hazen SL, Jarvelin MR, Khaw KT, Lehtim?ki T, Maerz W, Martin NG, Metspalu A, Mitchell BD, Montgomery GW, Moore C, Navis G, Pirastu M, Pramstaller PP, Ramirez-Solis R, Schadt E, Scott J, Shuldiner AR, Smith GD, Smith JG, Snieder H, Sorice R, Spector TD, Stefansson K, Stumvoll M, Tang WH, Toniolo D, T?njes A, Visscher PM, Vollenweider P, Wareham NJ, Wolffenbuttel BH, Boomsma DI, Beckmann JS, Dedoussis GV, Deloukas P, Ferreira MA, Sanna S, Uda M, Hicks AA, Penninger JM, Gieger C, Kooner JS, Ouwehand WH, Soranzo N, Chambers JC. Seventy-five genetic loci influencing the human red blood cell. Nature. 2012 Dec 20; 492(7429):369-75. PMID: 23222517.
      Citations:    
    80. Ju X, Ertel A, Casimiro MC, Yu Z, Meng H, McCue PA, Walters R, Fortina P, Lisanti MP, Pestell RG. Novel oncogene-induced metastatic prostate cancer cell lines define human prostate cancer progression signatures. Cancer Res. 2013 Jan 15; 73(2):978-89. PMID: 23204233.
      Citations:    
    81. Kricka LJ, Pollak ES, Fortina P. Recent Developments in Miniaturized PCR-Microchips, Microarrays and Microdroplets. EJIFCC. 2012 Oct; 23(3):76-9. PMID: 27683419.
      Citations:    
    82. Mitropoulos K, Innocenti F, van Schaik RH, Lezhava A, Tzimas G, Kollia P, Macek M, Fortina P, Patrinos GP. Institutional Profile: Golden Helix Institute of Biomedical Research: interdisciplinary research and educational activities in pharmacogenomics and personalized medicine. Pharmacogenomics. 2012 Mar; 13(4):387-92. PMID: 22379996.
      Citations:    
    83. Casimiro MC, Crosariol M, Loro E, Ertel A, Yu Z, Dampier W, Saria EA, Papanikolaou A, Stanek TJ, Li Z, Wang C, Fortina P, Addya S, Tozeren A, Knudsen ES, Arnold A, Pestell RG. ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice. J Clin Invest. 2012 Mar; 122(3):833-43. PMID: 22307325.
      Citations:    
    84. Danjou F, Anni F, Perseu L, Satta S, Dess? C, Lai ME, Fortina P, Devoto M, Galanello R. Genetic modifiers of ?-thalassemia and clinical severity as assessed by age at first transfusion. Haematologica. 2012 Jul; 97(7):989-93. PMID: 22271886.
      Citations:    
    85. Katiyar S, Jiao X, Addya S, Ertel A, Covarrubias Y, Rose V, Casimiro MC, Zhou J, Lisanti MP, Nasim T, Fortina P, Pestell RG. Mammary gland selective excision of c-jun identifies its role in mRNA splicing. Cancer Res. 2012 Feb 15; 72(4):1023-34. PMID: 22174367.
      Citations:    
    86. Yasuhara R, Ohta Y, Yuasa T, Kondo N, Hoang T, Addya S, Fortina P, Pacifici M, Iwamoto M, Enomoto-Iwamoto M. Roles of ?-catenin signaling in phenotypic expression and proliferation of articular cartilage superficial zone cells. Lab Invest. 2011 Dec; 91(12):1739-52. PMID: 21968810.
      Citations:    
    87. Londin ER, Keller MA, D'Andrea MR, Delgrosso K, Ertel A, Surrey S, Fortina P. Whole-exome sequencing of DNA from peripheral blood mononuclear cells (PBMC) and EBV-transformed lymphocytes from the same donor. BMC Genomics. 2011 Sep 26; 12:464. PMID: 21943378.
      Citations:    
    88. Kricka LJ, Fortina P, Mai Y, Patrinos GP. Direct-access genetic testing: the view from Europe. Nat Rev Genet. 2011 Sep 13; 12(10):670. PMID: 21915107.
      Citations:    
    89. Witkiewicz AK, Rivadeneira DB, Ertel A, Kline J, Hyslop T, Schwartz GF, Fortina P, Knudsen ES. Association of RB/p16-pathway perturbations with DCIS recurrence: dependence on tumor versus tissue microenvironment. Am J Pathol. 2011 Sep; 179(3):1171-8. PMID: 21756866.
      Citations:    
    90. McClendon AK, Dean JL, Ertel A, Fu Z, Rivadeneira DB, Reed CA, Bourgo RJ, Witkiewicz A, Addya S, Mayhew CN, Grimes HL, Fortina P, Knudsen ES. RB and p53 cooperate to prevent liver tumorigenesis in response to tissue damage. Gastroenterology. 2011 Oct; 141(4):1439-50. PMID: 21704587.
      Citations:    
    91. Villa N, Bentivegna A, Ertel A, Redaelli S, Colombo C, Nacinovich R, Broggi F, Lissoni S, Bungaro S, Addya S, Fortina P, Dalpr? L. A de novo supernumerary genomic discontinuous ring chromosome 21 in a child with mild intellectual disability. Am J Med Genet A. 2011 Jun; 155A(6):1425-31. PMID: 21574245.
      Citations:    
    92. Bryant KG, Camacho J, Jasmin JF, Wang C, Addya S, Casimiro MC, Fortina P, Balasubramaniam S, Knudsen KE, Schwarting R, Lisanti MP, Mercier I. Caveolin-1 overexpression enhances androgen-dependent growth and proliferation in the mouse prostate. Int J Biochem Cell Biol. 2011 Sep; 43(9):1318-29. PMID: 21601007.
      Citations:    
    93. Patrinos GP, Innocenti F, Cox N, Fortina P. Genetic Analysis in Translational Medicine: The 2010 GOLDEN HELIX Symposium. Hum Mutat. 2011 Jun; 32(6):698-703. PMID: 21438074.
      Citations:    
    94. Imai K, Kricka LJ, Fortina P. Concordance study of 3 direct-to-consumer genetic-testing services. Clin Chem. 2011 Mar; 57(3):518-21. PMID: 21159896.
      Citations:    
    95. Martinez Cantarin MP, Ertel A, Deloach S, Fortina P, Scott K, Burns TL, Falkner B. Variants in genes involved in functional pathways associated with hypertension in African Americans. Clin Transl Sci. 2010 Dec; 3(6):279-86. PMID: 21167003.
      Citations:    
    96. Del Galdo F, Wermuth PJ, Addya S, Fortina P, Jimenez SA. NF?B activation and stimulation of chemokine production in normal human macrophages by the gadolinium-based magnetic resonance contrast agent Omniscan: possible role in the pathogenesis of nephrogenic systemic fibrosis. Ann Rheum Dis. 2010 Nov; 69(11):2024-33. PMID: 20959327.
      Citations:    
    97. Kricka LJ, Imai K, Fortina P. Analytical ancestry: evolution of the array in analysis. Clin Chem. 2010 Dec; 56(12):1797-803. PMID: 20943847.
      Citations:    
    98. Fortina P, Kricka LJ. Nanotechnology: improving clinical testing? Clin Chem. 2010 Sep; 56(9):1384-9. PMID: 20802097.
      Citations:    
    99. Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, Casimiro MC, Wang C, Fortina P, Addya S, Pestell RG, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the "reverse Warburg effect": a transcriptional informatics analysis with validation. Cell Cycle. 2010 Jun 01; 9(11):2201-19. PMID: 20519932.
      Citations:    
    100. Gu L, Vogiatzi P, Puhr M, Dagvadorj A, Lutz J, Ryder A, Addya S, Fortina P, Cooper C, Leiby B, Dasgupta A, Hyslop T, Bubendorf L, Alanen K, Mirtti T, Nevalainen MT. Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. Endocr Relat Cancer. 2010 Jun; 17(2):481-93. PMID: 20233708.
      Citations:    
    101. Martinoli E, Zuccotti GV, Pogliani L, Volont? M, Venturin M, Fortina P, Ertel A, Redaelli S, Riva P, Dalpr? L. A tandem duplication of chromosome 21 in a newborn showing a phenotype inconsistent with Down syndrome. Am J Med Genet A. 2010 Apr; 152A(4):1043-5. PMID: 20358625.
      Citations:    
    102. Saraiya M, Nasser R, Zeng Y, Addya S, Ponnappan RK, Fortina P, Anderson DG, Albert TJ, Shapiro IM, Risbud MV. Reversine enhances generation of progenitor-like cells by dedifferentiation of annulus fibrosus cells. Tissue Eng Part A. 2010 Apr; 16(4):1443-55. PMID: 19947906.
      Citations:    
    103. Gu L, Dagvadorj A, Lutz J, Leiby B, Bonuccelli G, Lisanti MP, Addya S, Fortina P, Dasgupta A, Hyslop T, Bubendorf L, Nevalainen MT. Transcription factor Stat3 stimulates metastatic behavior of human prostate cancer cells in vivo, whereas Stat5b has a preferential role in the promotion of prostate cancer cell viability and tumor growth. Am J Pathol. 2010 Apr; 176(4):1959-72. PMID: 20167868.
      Citations:    
    104. Pavlides S, Whitaker-Menezes D, Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, Casimiro MC, Wang C, Fortina P, Addya S, Pestell RG, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle. 2009 Dec; 8(23):3984-4001. PMID: 19923890.
      Citations:    
    105. Liu M, Casimiro MC, Wang C, Shirley LA, Jiao X, Katiyar S, Ju X, Li Z, Yu Z, Zhou J, Johnson M, Fortina P, Hyslop T, Windle JJ, Pestell RG. p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo. Proc Natl Acad Sci U S A. 2009 Nov 10; 106(45):19035-9. PMID: 19858489.
      Citations:    
    106. Bernardini L, Alesi V, Loddo S, Novelli A, Bottillo I, Battaglia A, Digilio MC, Zampino G, Ertel A, Fortina P, Surrey S, Dallapiccola B. High-resolution SNP arrays in mental retardation diagnostics: how much do we gain? Eur J Hum Genet. 2010 Feb; 18(2):178-85. PMID: 19809473.
      Citations:    
    107. Feldman G, Dalsey C, Fertala K, Azimi D, Fortina P, Devoto M, Pacifici M, Parvizi J. The Otto Aufranc Award: Identification of a 4 Mb region on chromosome 17q21 linked to developmental dysplasia of the hip in one 18-member, multigeneration family. Clin Orthop Relat Res. 2010 Feb; 468(2):337-44. PMID: 19756907.
      Citations:    
    108. Levi L, Pekarski I, Gutman E, Fortina P, Hyslop T, Biran J, Levavi-Sivan B, Lubzens E. Revealing genes associated with vitellogenesis in the liver of the zebrafish (Danio rerio) by transcriptome profiling. BMC Genomics. 2009 Mar 31; 10:141. PMID: 19335895.
      Citations:    
    109. Kricka LJ, Fortina P. Analytical ancestry: "firsts" in fluorescent labeling of nucleosides, nucleotides, and nucleic acids. Clin Chem. 2009 Apr; 55(4):670-83. PMID: 19233914.
      Citations:    
    110. Specchia C, Scott K, Fortina P, Devoto M, Falkner B. Association of a polymorphic variant of the adiponectin gene with insulin resistance in african americans. Clin Transl Sci. 2008 Dec; 1(3):194-9. PMID: 20443850.
      Citations:    
    111. Augustus AS, Buchanan J, Gutman E, Rengo G, Pestell RG, Fortina P, Koch WJ, Bensadoun A, Abel ED, Lisanti MP. Hearts lacking caveolin-1 develop hypertrophy with normal cardiac substrate metabolism. Cell Cycle. 2008 Aug 15; 7(16):2509-18. PMID: 18719368.
      Citations:    
    112. Battistella S, Damin F, Chiari M, Delgrosso K, Surrey S, Fortina P, Ferrari M, Cremonesi L. Genotyping beta-globin gene mutations on copolymer-coated glass slides with the ligation detection reaction. Clin Chem. 2008 Oct; 54(10):1657-63. PMID: 18703765.
      Citations:    
    113. Augustus AS, Buchanan J, Addya S, Rengo G, Pestell RG, Fortina P, Koch WJ, Bensadoun A, Abel ED, Lisanti MP. Substrate uptake and metabolism are preserved in hypertrophic caveolin-3 knockout hearts. Am J Physiol Heart Circ Physiol. 2008 Aug; 295(2):H657-66. PMID: 18552160.
      Citations:    
    114. Barbarotto E, Secchiero P, Dasgupta A, Fortina P, Calin GA, Hyslop T. MicroRNAs as new players in the genomic galaxy and disease puzzles. Clin Transl Sci. 2008 May; 1(1):50-6. PMID: 20443818.
      Citations:    
    115. Chetta M, Drmanac A, Santacroce R, Grandone E, Surrey S, Fortina P, Margaglione M. Identification of FVIII gene mutations in patients with hemophilia A using new combinatorial sequencing by hybridization. Indian J Hum Genet. 2008 May; 14(2):55-64. PMID: 20300295.
      Citations:    
    116. Fortina P, Surrey S. Digital mRNA profiling. Nat Biotechnol. 2008 Mar; 26(3):293-4. PMID: 18327237.
      Citations:    
    117. George RE, Attiyeh EF, Li S, Moreau LA, Neuberg D, Li C, Fox EA, Meyerson M, Diller L, Fortina P, Look AT, Maris JM. Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays. PLoS One. 2007 Feb 28; 2(2):e255. PMID: 17327916.
      Citations:    
    118. Fortina P, Kricka LJ, Graves DJ, Park J, Hyslop T, Tam F, Halas N, Surrey S, Waldman SA. Applications of nanoparticles to diagnostics and therapeutics in colorectal cancer. Trends Biotechnol. 2007 Apr; 25(4):145-52. PMID: 17316852.
      Citations:    
    119. Patel P, Shiao YH, Fortina P. Multiplex pyrosequencing for DNA variation analysis. Methods Mol Biol. 2007; 373:75-88. PMID: 17185759.
      Citations:    
    120. Waldman SA, Fortina P, Surrey S, Hyslop T, Kricka LJ, Graves DJ. Opportunities for near-infrared thermal ablation of colorectal metastases by guanylyl cyclase C-targeted gold nanoshells. Future Oncol. 2006 Dec; 2(6):705-16. PMID: 17155897.
      Citations:    
    121. Kricka LJ, Master SR, Joos TO, Fortina P. Current perspectives in protein array technology. Ann Clin Biochem. 2006 Nov; 43(Pt 6):457-67. PMID: 17132276.
      Citations:    
    122. Stewart J, Ware J, Fortina P, Breaux J, Gulati S, Kennedy A. L-selenomethionine modulates high LET radiation-induced alterations of gene expression in cultured human thyroid cells. Oncol Rep. 2006 Sep; 16(3):569-74. PMID: 16865257.
      Citations:    
    123. Schirinzi A, Drmanac S, Dallapiccola B, Huang S, Scott K, De Luca A, Swanson D, Drmanac R, Surrey S, Fortina P. Combinatorial sequencing-by-hybridization: analysis of the NF1 gene. Genet Test. 2006; 10(1):8-17. PMID: 16544997.
      Citations:    
    124. Maris JM, Hii G, Gelfand CA, Varde S, White PS, Rappaport E, Surrey S, Fortina P. Region-specific detection of neuroblastoma loss of heterozygosity at multiple loci simultaneously using a SNP-based tag-array platform. Genome Res. 2005 Aug; 15(8):1168-76. PMID: 16077016.
      Citations:    
    125. Ferraris A, Knafelz D, Torres B, Fortina P, Castro M, Dallapiccola B. Analysis of CARD15 gene variants in Italian pediatric patients with inflammatory bowel diseases. J Pediatr. 2005 Aug; 147(2):272-3. PMID: 16126067.
      Citations:    
    126. Kricka LJ, Park JY, Li SF, Fortina P. Miniaturized detection technology in molecular diagnostics. Expert Rev Mol Diagn. 2005 Jul; 5(4):549-59. PMID: 16013973.
      Citations:    
    127. Fortina P, Kricka LJ, Surrey S, Grodzinski P. Nanobiotechnology: the promise and reality of new approaches to molecular recognition. Trends Biotechnol. 2005 Apr; 23(4):168-73. PMID: 15780707.
      Citations:    
    128. Chen W, Tang Z, Fortina P, Patel P, Addya S, Surrey S, Acheampong EA, Mukhtar M, Pomerantz RJ. Ethanol potentiates HIV-1 gp120-induced apoptosis in human neurons via both the death receptor and NMDA receptor pathways. Virology. 2005 Mar 30; 334(1):59-73. PMID: 15749123.
      Citations:    
    129. Panaro NJ, Lou XJ, Fortina P, Kricka LJ, Wilding P. Micropillar array chip for integrated white blood cell isolation and PCR. Biomol Eng. 2005 Feb; 21(6):157-62. PMID: 15748689.
      Citations:    
    130. Lou XJ, Panaro NJ, Wilding P, Fortina P, Kricka LJ. Mutation detection using ligase chain reaction in passivated silicon-glass microchips and microchip capillary electrophoresis. Biotechniques. 2004 Sep; 37(3):392, 394, 396-8. PMID: 15470893.
      Citations:    
    131. Cowie S, Drmanac S, Swanson D, Delgrosso K, Huang S, du Sart D, Drmanac R, Surrey S, Fortina P. Identification of APC gene mutations in colorectal cancer using universal microarray-based combinatorial sequencing-by-hybridization. Hum Mutat. 2004 Sep; 24(3):261-71. PMID: 15300853.
      Citations:    
    132. Tang Z, McGowan BS, Huber SA, McTiernan CF, Addya S, Surrey S, Kubota T, Fortina P, Higuchi Y, Diamond MA, Wyre DS, Feldman AM. Gene expression profiling during the transition to failure in TNF-alpha over-expressing mice demonstrates the development of autoimmune myocarditis. J Mol Cell Cardiol. 2004 Apr; 36(4):515-30. PMID: 15081311.
      Citations:    
    133. Panaro NJ, Lou XJ, Fortina P, Kricka LJ, Wilding P. Surface effects on PCR reactions in multichip microfluidic platforms. Biomed Microdevices. 2004 Mar; 6(1):75-80. PMID: 15307448.
      Citations:    
    134. Lou XJ, Panaro NJ, Wilding P, Fortina P, Kricka LJ. Increased amplification efficiency of microchip-based PCR by dynamic surface passivation. Biotechniques. 2004 Feb; 36(2):248-52. PMID: 14989089.
      Citations:    
    135. Andriulli A, Annese V, Latiano A, Palmieri O, Fortina P, Ardizzone S, Cottone M, D'Inca R, Riegler G, Andruilli A. The frame-shift mutation of the NOD2/CARD15 gene is significantly increased in ulcerative colitis: an *IG-IBD study. Gastroenterology. 2004 Feb; 126(2):625-7. PMID: 14765396.
      Citations:    
    136. Foglieni B, Cremonesi L, Travi M, Ravani A, Giambona A, Rosatelli MC, Perra C, Fortina P, Ferrari M. Beta-thalassemia microelectronic chip: a fast and accurate method for mutation detection. Clin Chem. 2004 Jan; 50(1):73-9. PMID: 14709638.
      Citations:    
    137. Kricka LJ, Joos T, Fortina P. Protein microarrays: a literature survey. Clin Chem. 2003 Dec; 49(12):2109. PMID: 14633898.
      Citations:    
    138. Annese V, Latiano A, Palmieri O, Li HH, Forabosco P, Ferraris A, Andriulli A, Vecchi M, Ardizzone S, Cottone M, Dallapiccola B, Rappaport E, Fortina P, Devoto M. Linkage of ulcerative colitis to the pericentromeric region of chromosome 16 in Italian inflammatory bowel disease families is independent of the presence of common CARD15 mutations. J Med Genet. 2003 Nov; 40(11):837-41. PMID: 14627676.
      Citations:    
    139. Palmieri O, Toth S, Ferraris A, Andriulli A, Latiano A, Annese V, Dallapiccola B, Vecchi M, Devoto M, Surrey S, Fortina P. CARD15 genotyping in inflammatory bowel disease patients by multiplex pyrosequencing. Clin Chem. 2003 Oct; 49(10):1675-9. PMID: 14500598.
      Citations:    
    140. Kajiyama T, Miyahara Y, Kricka LJ, Wilding P, Graves DJ, Surrey S, Fortina P. Genotyping on a thermal gradient DNA chip. Genome Res. 2003 Mar; 13(3):467-75. PMID: 12618377.
      Citations:    
    141. Santacroce R, Ratti A, Caroli F, Foglieni B, Ferraris A, Cremonesi L, Margaglione M, Seri M, Ravazzolo R, Restagno G, Dallapiccola B, Rappaport E, Pollak ES, Surrey S, Ferrari M, Fortina P. Analysis of clinically relevant single-nucleotide polymorphisms by use of microelectronic array technology. Clin Chem. 2002 Dec; 48(12):2124-30. PMID: 12446467.
      Citations:    
    142. Kudaravalli R, Tidd T, Pinotti M, Ratti A, Santacroce R, Margaglione M, Dallapiccola B, Bernardi F, Fortina P, Devoto M, Pollak ES. Polymorphic changes in the 5' flanking region of factor VII have a combined effect on promoter strength. Thromb Haemost. 2002 Nov; 88(5):763-7. PMID: 12428091.
      Citations:    
    143. Ferraris A, Rappaport E, Santacroce R, Pollak E, Krantz I, Toth S, Lysholm F, Margaglione M, Restagno G, Dallapiccola B, Surrey S, Fortina P. Pyrosequencing for detection of mutations in the connexin 26 (GJB2) and mitochondrial 12S RNA (MTRNR1) genes associated with hereditary hearing loss. Hum Mutat. 2002 Oct; 20(4):312-20. PMID: 12325027.
      Citations:    
    144. Kricka LJ, Fortina P. Microchips: an all-language literature survey including books and patents. Clin Chem. 2002 Sep; 48(9):1620-2. PMID: 12194954.
      Citations:    
    145. Fortina P, Surrey S, Kricka LJ. Molecular diagnostics: hurdles for clinical implementation. Trends Mol Med. 2002 Jun; 8(6):264-6. PMID: 12067610.
      Citations:    
    146. Bason L, Dudley T, Lewis K, Shah U, Potsic W, Ferraris A, Fortina P, Rappaport E, Krantz ID. Homozygosity for the V37I Connexin 26 mutation in three unrelated children with sensorineural hearing loss. Clin Genet. 2002 Jun; 61(6):459-64. PMID: 12121355.
      Citations:    
    147. Su HJ, Surrey S, McKenzie SE, Fortina P, Graves DJ. Kinetics of heterogeneous hybridization on indium tin oxide surfaces with and without an applied potential. Electrophoresis. 2002 May; 23(10):1551-7. PMID: 12116168.
      Citations:    
    148. Graves DJ, Su HJ, Addya S, Surrey S, Fortina P. Four-laser scanning confocal system for microarray analysis. Biotechniques. 2002 Feb; 32(2):346-8, 350, 352, 354. PMID: 11848412.
      Citations:    
    149. Kricka LJ, Fortina P, Panaro NJ, Wilding P, Alonso-Amigo G, Becker H. Fabrication of plastic microchips by hot embossing. Lab Chip. 2002 Feb; 2(1):1-4. PMID: 15100847.
      Citations:    
    150. Kricka LJ, Fortina P. Nanotechnology and applications: an all-language literature survey including books and patents. Clin Chem. 2002; 48(4):662-5. PMID: 11901071.
      Citations:    
    151. Kricka LJ, Fortina P. Microarray technology and applications: an all-language literature survey including books and patents. Clin Chem. 2001 Aug; 47(8):1479-82. PMID: 11468245.
      Citations:    
    152. Pollak ES, Feng L, Ahadian H, Fortina P. Microarray-based genetic analyses for studying susceptibility to arterial and venous thrombotic disorders. Ital Heart J. 2001 Aug; 2(8):568-72. PMID: 11577828.
      Citations:    
    153. Yuen PK, Kricka LJ, Fortina P, Panaro NJ, Sakazume T, Wilding P. Microchip module for blood sample preparation and nucleic acid amplification reactions. Genome Res. 2001 Mar; 11(3):405-12. PMID: 11230164.
      Citations:    
    154. Mansfield ES, Wilson RB, Fortina P. Analysis of short tandem repeat markers by capillary array electrophoresis. Methods Mol Biol. 2001; 163:151-61. PMID: 11242940.
      Citations:    
    155. Fortina P, Cheng J, Kricka LJ, Waters LC, Jacobson SC, Wilding P, Ramsey JM. DOP-PCR amplification of whole genomic DNA and microchip-based capillary electrophoresis. Methods Mol Biol. 2001; 163:211-9. PMID: 11242946.
      Citations:    
    156. Panaro NJ, Yuen PK, Sakazume T, Fortina P, Kricka LJ, Wilding P. Evaluation of DNA fragment sizing and quantification by the agilent 2100 bioanalyzer. Clin Chem. 2000 Nov; 46(11):1851-3. PMID: 11067828.
      Citations:    
    157. Fortina P, Delgrosso K, Sakazume T, Santacroce R, Moutereau S, Su HJ, Graves D, McKenzie S, Surrey S. Simple two-color array-based approach for mutation detection. Eur J Hum Genet. 2000 Nov; 8(11):884-94. PMID: 11093279.
      Citations:    
    158. Forabosco P, Collins A, Latiano A, Annese V, Clementi M, Andriulli A, Fortina P, Devoto M, Morton NE. Combined segregation and linkage analysis of inflammatory bowel disease in the IBD1 region using severity to characterise Crohn's disease and ulcerative colitis. On behalf of the GISC. Eur J Hum Genet. 2000 Nov; 8(11):846-52. PMID: 11093274.
      Citations:    
    159. Margaglione M, Santacroce R, Colaizzo D, Seripa D, Vecchione G, Lupone MR, De Lucia D, Fortina P, Grandone E, Perricone C, Di Minno G. A G-to-A mutation in IVS-3 of the human gamma fibrinogen gene causing afibrinogenemia due to abnormal RNA splicing. Blood. 2000 Oct 01; 96(7):2501-5. PMID: 11001903.
      Citations:    
    160. Santacroce R, Bossone A, Brancaccio V, Fortina P, Margaglione M. In the presence of other inherited or acquired high-risk situations, the FV Cambridge mutation may be an additional thrombophilic risk factor, through its effect on APC sensitivity. Thromb Haemost. 2000 Jun; 83(6):963-4. PMID: 10896257.
      Citations:    
    161. Ming JE, Blagowidow N, Knoll JH, Rollings L, Fortina P, McDonald-McGinn DM, Spinner NB, Zackai EH. Submicroscopic deletion in cousins with Prader-Willi syndrome causes a grandmatrilineal inheritance pattern: effects of imprinting. Am J Med Genet. 2000 May 01; 92(1):19-24. PMID: 10797418.
      Citations:    
    162. Gasparini P, Rabionet R, Barbujani G, Mel?hionda S, Petersen M, Br?ndum-Nielsen K, Metspalu A, Oitmaa E, Pisano M, Fortina P, Zelante L, Estivill X. High carrier frequency of the 35delG deafness mutation in European populations. Genetic Analysis Consortium of GJB2 35delG. Eur J Hum Genet. 2000 Jan; 8(1):19-23. PMID: 10713883.
      Citations:    
    163. Restagno G, Gomez AM, Sbaiz L, De Gobbi M, Roetto A, Bertino E, Fabris C, Fiorucci GC, Fortina P, Camaschella C. A pilot C282Y hemochromatosis screening in Italian newborns by TaqMan technology. Genet Test. 2000; 4(2):177-81. PMID: 10953958.
      Citations:    
    164. Annese V, Latiano A, Bovio P, Forabosco P, Piepoli A, Lombardi G, Andreoli A, Astegiano M, Gionchetti P, Riegler G, Sturniolo GC, Clementi M, Rappaport E, Fortina P, Devoto M, Gasparini P, Andriulli A. Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus--a GISC study. Eur J Hum Genet. 1999 Jul; 7(5):567-73. PMID: 10439963.
      Citations:    
    165. Gasparini P, Estivill X, Fortina P. Vestibular and hearing loss in genetic and metabolic disorders. Curr Opin Neurol. 1999 Feb; 12(1):35-9. PMID: 10097882.
      Citations:    
    166. Gasparini P, Arbustini E, Restagno G, Zelante L, Stanziale P, Gatta L, Sbaiz L, Sedita AM, Banchieri N, Sapone L, Fiorucci GC, Brinson E, Shulse E, Rappaport E, Fortina P. Analysis of 31 CFTR mutations by polymerase chain reaction/oligonucleotide ligation assay in a pilot screening of 4476 newborns for cystic fibrosis. J Med Screen. 1999; 6(2):67-9. PMID: 10444722.
      Citations:    
    167. Graves DJ, Su HJ, McKenzie SE, Surrey S, Fortina P. System for preparing microhybridization arrays on glass slides. Anal Chem. 1998 Dec 01; 70(23):5085-92. PMID: 9852790.
      Citations:    
    168. Arbustini E, Diegoli M, Fasani R, Grasso M, Morbini P, Banchieri N, Bellini O, Dal Bello B, Pilotto A, Magrini G, Campana C, Fortina P, Gavazzi A, Narula J, Vigan? M. Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy. Am J Pathol. 1998 Nov; 153(5):1501-10. PMID: 9811342.
      Citations:    
    169. Meyer GA, Blum NJ, Hitchcock W, Fortina P. Absence of the fragile X CGG trinucleotide repeat expansion in girls diagnosed with a pervasive developmental disorder. J Pediatr. 1998 Sep; 133(3):363-5. PMID: 9738717.
      Citations:    
    170. McKenzie SE, Mansfield E, Rappaport E, Surrey S, Fortina P. Parallel molecular genetic analysis. Eur J Hum Genet. 1998 Sep-Oct; 6(5):417-29. PMID: 9801865.
      Citations:    
    171. Cheng J, Waters LC, Fortina P, Hvichia G, Jacobson SC, Ramsey JM, Kricka LJ, Wilding P. Degenerate oligonucleotide primed-polymerase chain reaction and capillary electrophoretic analysis of human DNA on microchip-based devices. Anal Biochem. 1998 Mar 15; 257(2):101-6. PMID: 9514777.
      Citations:    
    172. Wilding P, Kricka LJ, Cheng J, Hvichia G, Shoffner MA, Fortina P. Integrated cell isolation and polymerase chain reaction analysis using silicon microfilter chambers. Anal Biochem. 1998 Mar 15; 257(2):95-100. PMID: 9514776.
      Citations:    
    173. Estivill X, Fortina P, Surrey S, Rabionet R, Melchionda S, D'Agruma L, Mansfield E, Rappaport E, Govea N, Mil? M, Zelante L, Gasparini P. Connexin-26 mutations in sporadic and inherited sensorineural deafness. Lancet. 1998 Feb 07; 351(9100):394-8. PMID: 9482292.
      Citations:    
    174. Fortina P. Applications of emerging technologies to the study of human genetics. Eur J Hum Genet. 1998 Jan; 6(1):2-3. PMID: 9781009.
      Citations:    
    175. Mansfield ES, Vainer M, Harris DW, Gasparini P, Estivill X, Surrey S, Fortina P. Rapid sizing of polymorphic microsatellite markers by capillary array electrophoresis. J Chromatogr A. 1997 Sep 26; 781(1-2):295-305. PMID: 9368392.
      Citations:    
    176. Zelante L, Gasparini P, Estivill X, Melchionda S, D'Agruma L, Govea N, Mil? M, Monica MD, Lutfi J, Shohat M, Mansfield E, Delgrosso K, Rappaport E, Surrey S, Fortina P. Connexin26 mutations associated with the most common form of non-syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans. Hum Mol Genet. 1997 Sep; 6(9):1605-9. PMID: 9285800.
      Citations:    
    177. Larson PJ, Friedman DF, Reilly MP, Kattamis AC, Asakura T, Fortina P, Cohen AR, Kim HC, Manno CS. The presurgical management with erythrocytapheresis of a patient with a high-oxygen-affinity, unstable Hb variant (Hb Bryn Mawr). Transfusion. 1997 Jul; 37(7):703-7. PMID: 9225933.
      Citations:    
    178. Camaschella C, Kattamis AC, Petroni D, Roetto A, Sivera P, Sbaiz L, Cohen A, Ohene-Frempong K, Trifillis P, Surrey S, Fortina P. Different hematological phenotypes caused by the interaction of triplicated alpha-globin genes and heterozygous beta-thalassemia. Am J Hematol. 1997 Jun; 55(2):83-8. PMID: 9209003.
      Citations:    
    179. Fortina P, Cheng J, Shoffner MA, Surrey S, Hitchcock WM, Kricka LJ, Wilding P. Diagnosis of Duchenne/Becker muscular dystrophy and quantitative identification of carrier status by use of entangled solution capillary electrophoresis. Clin Chem. 1997 May; 43(5):745-51. PMID: 9166226.
      Citations:    
    180. Kattamis AC, Kelly KM, Ohene-Frempong K, Reilly MP, Keller M, Cubeddu R, Adachi K, Surrey S, Fortina P. Hb Osler [beta 145(HC2)Tyr-->Asp] results from posttranslational modification. Hemoglobin. 1997 Mar; 21(2):109-20. PMID: 9101280.
      Citations:    
    181. Gasparini P, Estivill X, Volpini V, Totaro A, Castellvi-Bel S, Govea N, Mila M, Della Monica M, Ventruto V, De Benedetto M, Stanziale P, Zelante L, Mansfield ES, Sandkuijl L, Surrey S, Fortina P. Linkage of DFNB1 to non-syndromic neurosensory autosomal-recessive deafness in Mediterranean families. Eur J Hum Genet. 1997 Mar-Apr; 5(2):83-8. PMID: 9195157.
      Citations:    
    182. Tamary H, Klinger G, Shalmon L, Attias D, Fortina P, Kobayashi M, Surrey S, Zaizov R. alpha-thalassemia caused by a 16 bp deletion in the 3' untranslated region of the alpha 2-globin gene including the first nucleotide of the poly A signal sequence. Hemoglobin. 1997 Mar; 21(2):121-30. PMID: 9101281.
      Citations:    
    183. Kattamis AC, Camaschella C, Sivera P, Surrey S, Fortina P. Human alpha-thalassemia syndromes: detection of molecular defects. Am J Hematol. 1996 Oct; 53(2):81-91. PMID: 8892732.
      Citations:    
    184. Mansfield ES, Vainer M, Enad S, Barker DL, Harris D, Rappaport E, Fortina P. Sensitivity, reproducibility, and accuracy in short tandem repeat genotyping using capillary array electrophoresis. Genome Res. 1996 Sep; 6(9):893-903. PMID: 8889558.
      Citations:    
    185. Camaschella C, Roetto A, Gasparini P, Piperno A, Fortina P, Surrey S, Rappaport E. Allelic association of microsatellites of 6p in Italian hemochromatosis patients. Hum Genet. 1996 Apr; 97(4):476-81. PMID: 8834246.
      Citations:    
    186. Arbustini E, Grasso M, Fasani R, Klersy C, Diegoli M, Porcu E, Banchieri N, Fortina P, Danesino C, Specchia G. Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction. Br Heart J. 1995 Dec; 74(6):584-91. PMID: 8541160.
      Citations:    
    187. Kobayashi M, Kaplan BS, Bellah RD, Sartore M, Rappaport E, Steele MW, Mansfield E, Gasparini P, Surrey S, Fortina P. Infundibulopelvic stenosis, multicystic kidney, and calyectasis in a kindred: clinical observations and genetic analysis. Am J Med Genet. 1995 Nov 06; 59(2):218-24. PMID: 8588589.
      Citations:    
    188. Kobayashi M, Rappaport E, Blasband A, Semeraro A, Sartore M, Surrey S, Fortina P. Fluorescence-based DNA minisequence analysis for detection of known single-base changes in genomic DNA. Mol Cell Probes. 1995 Jun; 9(3):175-82. PMID: 7477010.
      Citations:    
    189. Mansfield ES, Worley JM, McKenzie SE, Surrey S, Rappaport E, Fortina P. Nucleic acid detection using non-radioactive labelling methods. Mol Cell Probes. 1995 Jun; 9(3):145-56. PMID: 7477006.
      Citations:    
    190. Spinner NB, Rand EB, Fortina P, Genin A, Taub R, Semeraro A, Piccoli DA. Cytologically balanced t(2;20) in a two-generation family with alagille syndrome: cytogenetic and molecular studies. Am J Hum Genet. 1994 Aug; 55(2):238-43. PMID: 8037203.
      Citations:    
    191. Iolascon A, Parrella T, Perrotta S, Guardamagna O, Coates PM, Sartore M, Surrey S, Fortina P. Rapid detection of medium chain acyl-CoA dehydrogenase gene mutations by non-radioactive, single strand conformation polymorphism minigels. J Med Genet. 1994 Jul; 31(7):551-4. PMID: 7966191.
      Citations:    
    192. Fortina P, Parrella T, Sartore M, Gottardi E, Gabutti V, Delgrosso K, Mansfield E, Rappaport E, Schwartz E, Camaschella C, et al. Interaction of rare illegitimate recombination event and a poly A addition site mutation resulting in a severe form of alpha thalassemia. Blood. 1994 Jun 01; 83(11):3356-62. PMID: 8193372.
      Citations:    
    193. Poncz M, Rifat S, Coller BS, Newman PJ, Shattil SJ, Parrella T, Fortina P, Bennett JS. Glanzmann thrombasthenia secondary to a Gly273-->Asp mutation adjacent to the first calcium-binding domain of platelet glycoprotein IIb. J Clin Invest. 1994 Jan; 93(1):172-9. PMID: 8282784.
      Citations:    
    194. Mansfield ES, Robertson JM, Lebo RV, Lucero MY, Mayrand PE, Rappaport E, Parrella T, Sartore M, Surrey S, Fortina P. Duchenne/Becker muscular dystrophy carrier detection using quantitative PCR and fluorescence-based strategies. Am J Med Genet. 1993 Dec 15; 48(4):200-8. PMID: 7510932.
      Citations:    
    195. Mansfield ES, Blasband A, Kronick MN, Wrabetz L, Kaplan P, Rappaport E, Sartore M, Parrella T, Surrey S, Fortina P. Fluorescent approaches to diagnosis of Lesch-Nyhan syndrome and quantitative analysis of carrier status. Mol Cell Probes. 1993 Aug; 7(4):311-24. PMID: 8232348.
      Citations:    
    196. Fortina P, Conant R, Monokian G, Dotti G, Parrella T, Hitchcock W, Kant J, Scanlin T, Rappaport E, Schwartz E, et al. Non-radioactive detection of the most common mutations in the cystic fibrosis transmembrane conductance regulator gene by multiplex allele-specific polymerase chain reaction. Hum Genet. 1992 Dec; 90(4):375-8. PMID: 1282898.
      Citations:    
    197. Fortina P, Dotti G, Conant R, Monokian G, Parrella T, Hitchcock W, Rappaport E, Schwartz E, Surrey S. Detection of the most common mutations causing beta-thalassemia in Mediterraneans using a multiplex amplification refractory mutation system (MARMS). PCR Methods Appl. 1992 Nov; 2(2):163-6. PMID: 1477672.
      Citations:    
    198. Fortina P, Conant R, Parrella T, Rappaport E, Scanlin T, Schwartz E, Robertson JM, Surrey S. Fluorescence-based, multiplex allele-specific PCR (MASPCR) detection of the delta F508 deletion in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Mol Cell Probes. 1992 Aug; 6(4):353-6. PMID: 1382222.
      Citations:    
    199. Fortina P, Dianzani I, Serra A, Gottardi E, Saglio G, Farinasso L, Piga A, Gabutti V, Camaschella C. A newly-characterized alpha-thalassaemia-1 deletion removes the entire alpha-like globin gene cluster in an Italian family. Br J Haematol. 1991 Aug; 78(4):529-34. PMID: 1911344.
      Citations:    
    200. Fortina P, Delgrosso K, Werner E, Haines K, Rappaport E, Schwartz E, Surrey S. A greater than 200 kb deletion removing the entire beta-like globin gene cluster in a family of Irish descent. Hemoglobin. 1991; 15(1-2):23-41. PMID: 1717405.
      Citations:    
    201. Dianzani I, Farinasso L, Fortina P, Camaschella C, Ponzone R, Dahl HH, Cotton RG, Ponzone A. RFLPs of the phenylalanine hydroxylase gene in the Italian population. J Inherit Metab Dis. 1989; 12(2):162-5. PMID: 2569049.
      Citations:    
    202. Fortina P, Delgrosso K, Rappaport E, Werner E, Ballas S, Schwartz E, Surrey S. Large deletions encompassing the entire alpha- and beta-like globin gene clusters in humans. Prog Clin Biol Res. 1989; 316B:151-9. PMID: 2575754.
      Citations:    
    203. Fortina P, Delgrosso K, Rappaport E, Poncz M, Ballas SK, Schwartz E, Surrey S. A large deletion encompassing the entire alpha-like globin gene cluster in a family of northern European extraction. Nucleic Acids Res. 1988 Dec 09; 16(23):11223-35. PMID: 2905048.
      Citations:    
    204. Campogrande M, La Prova A, Cornaglia G, Fortina P, Viora E. [Early recognition of twin-to-twin transfusion syndrome. Differential diagnosis and therapeutic hypothesis]. Minerva Ginecol. 1986 Jun; 38(6):439-42. PMID: 3526196.
      Citations:    
    205. Fiandino G, Gabutti V, Messina M, Branca R, Fortina P, Ramenghi U, Saracco P, Miniero R. [Bone marrow aplasia]. Pediatr Med Chir. 1986 Jan-Feb; 8(1):3-8. PMID: 3523446.
      Citations:    
    206. Gabutti V, Amione C, Bess? C, Carpignano M, Fortina P, Leone L, Monteleone M, Cornaglia G, Viora E, Campogrande M. [Prenatal diagnosis of thalassemia: experience in Piedmont]. Minerva Pediatr. 1985 Sep 15; 37(17):625-7. PMID: 4079881.
      Citations:    
    207. Fortina P. [Public health. Conceived by the ones, realized by the others: home attendants of sick children]. Krankenpfl Soins Infirm. 1984 Apr; 77(4):83-4. PMID: 6325818.
      Citations:    
    208. Gabutti V, Piga A, Fortina P, Miniero R, Nicola P. Correlation between transfusion requirement, blood volume and haemoglobin level in homozygous beta-thalassaemia. Acta Haematol. 1980; 64(2):103-8. PMID: 6776764.
      Citations:    
    209. FORTINA P. [Treatment of scarlet fever]. Minerva Med. 1951 Jul 28; 42(46-47):114-8. PMID: 14863226.
      Citations:    
    210. FORTINA P, FORTINA A. [Therapy in post-diphtheric paralysis]. Minerva Med. 1949 Oct 27; 40(53 Pt 2):590-6. PMID: 15399009.
      Citations:    
    211. FORTINA P, CAGLIARDI B. Prothrombinemia in diphtheria. Arch Sci Med (Torino). 1948 Oct; 86(4):307-26. PMID: 18886625.
      Citations:    
    212. FORTINA P, FORTINA A. Scarlet fever therapy. Minerva Med. 1948 Aug 11; 39(32):119-23. PMID: 18879433.
      Citations:    
    213. FORTINA P. Therapy and prophylaxis of acute anterior poliomyelitis. Minerva Med. 1947 Aug 11; 38(32):116-24. PMID: 20258007.
      Citations:    
    214. FORTINA P, RAPELLINI M. Peritonsillar abscess and diphtheria. Minerva Med. 1947 Aug 11; 38(32):113-6. PMID: 20258006.
      Citations:    
    Fortina's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (915)
    Explore
    _
    Co-Authors (106)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _